Althea's Crystalomics® technology allows proteins and other large molecule products to be formulated as crystals. These formulations allow manufacturers to overcome stability and delivery challenges with products that need to be delivered at high concentrations or must be administered frequently. Crystalomics® offers a better solution for these challenging applications.
Protein Formulation Technology - Crystalomics®
High Concentration Formulations
- Suspension formulations of mAB’s have the potential of delivering higher doses in a smaller injection volume
- Potential for concentrations >200mg/ml
Sustained Release Formulations
- Extended release of a week or longer
- Good injectability with a low initial burst